Activating Compound | Comment | Organism | Structure |
---|---|---|---|
fructose 1,6-bisphosphate | FBP, molecular dynamics (MD) simulations of the human PKM2 (hPKM2) monomer in the absence (apo-hPKM2) or presence of FBP (hPKM2-FBP), the molecular dynamics simulations identify conformational changes in PKM2 associated with FBP binding, overview | Homo sapiens | |
fructose 1,6-bisphosphate | FBP, molecular dynamics simulations identify conformational changes in PKM2 associated with FBP binding | Mus musculus |
Protein Variants | Comment | Organism |
---|---|---|
additional information | molecular dynamics simulations are used to guide the design of mPKM2 internal light/oxygen/voltage-sensitive domain 2 (LOV2) fusion at position D24 (PiL[D24]), resulting in an engineered pyruvate kinase M2 (PKM2) variant that harbours an insertion of the light-sensing LOV2 domain from Avena Sativa within a region implicated in allosteric regulation by fructose 1,6-bisphosphate (FBP). The LOV2 photoreaction is preserved in the PiL[D24] chimera and causes secondary structure changes that are associated with a 30% decrease in the Km of the enzyme for phosphoenolpyruvate resulting in increased pyruvate kinase activity after light exposure. Importantly, this change in activity is reversible upon light withdrawal. Expression of PiL[D24] in cells leads to light-induced increase in labelling of pyruvate from glucose. Light induces a reversible increase in the enzymatic activity of purified PiL[D24]. Steady-state Michaelis-Menten kinetic parameters for PiL[D24] under dark and lit conditions determined by NMR spectroscopy at 21°C | Mus musculus |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
Mg2+ | required | Homo sapiens | |
Mg2+ | required | Mus musculus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | P14618 | - |
- |
Mus musculus | P52480 | - |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
muscle | - |
Homo sapiens | - |
muscle | - |
Mus musculus | - |
Synonyms | Comment | Organism |
---|---|---|
hPKM2 | - |
Homo sapiens |
mPKM2 | - |
Mus musculus |
General Information | Comment | Organism |
---|---|---|
malfunction | aberrant growth factor signalling and oxidative stress inhibit PKM2, which results in the diversion of glucose carbons into anabolic and redox regulating pathways that are essential for cell growth and survival. Proliferating PKM2-null tumour cells have no detectable PK expression, which likely reflects an adaptation that suppresses expression of PKM1 in these tumours. Consistent with a negative role of high PK activity in tumour growth, both exogenous expression of PKM1 or pharmacological activators that overcome endogenous PKM2-inhibiting mechanisms impede tumour growth by increasing cellular PK activity, effectively rendering endogenous PKM2 into a PKM1-like enzyme | Homo sapiens |
malfunction | aberrant growth factor signalling and oxidative stress inhibit PKM2, which results in the diversion of glucose carbons into anabolic and redox regulating pathways that are essential for cell growth and survival. Proliferating PKM2-null tumour cells have no detectable PK expression, which likely reflects an adaptation that suppresses expression of PKM1 in these tumours. Consistent with a negative role of high PK activity in tumour growth, both exogenous expression of PKM1 or pharmacological activators that overcome endogenous PKM2-inhibiting mechanisms impede tumour growth by increasing cellular PK activity, effectively rendering endogenous PKM2 into a PKM1-like enzyme | Mus musculus |
additional information | molecular dynamics (MD) simulations of the human PKM2 (hPKM2) monomer in the absence (apo-hPKM2) or presence of FBP (hPKM2-FBP), analysis of the mechanical response of PKM2 upon binding of FBP, overview | Homo sapiens |
physiological function | various intracellular mechanisms in cancer cells maintain PKM2 in a low-activity monomeric state and forced stabilisation of tetrameric PKM2 increases its enzymatic activity thereby impeding cell proliferation | Homo sapiens |
physiological function | various intracellular mechanisms in cancer cells maintain PKM2 in a low-activity monomeric state and forced stabilisation of tetrameric PKM2 increases its enzymatic activity thereby impeding cell proliferation | Mus musculus |